| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.926 | 0.003 | 0.926 | Hypoglycemic | 0.782 0.004 DBMET02948 | ||
| 0.702 | 0.033 | 0.936 | Alpha-glucosidase inhibitor | 0.936 0.005 DBMET02948 | DBMET02948 | |
| 0.637 | 0.022 | 0.778 | Cyclophilin D inhibitor | 0.778 0.008 DBMET02948 | DBMET02948 | |
| 0.599 | 0.004 | 0.599 | Chelator | 0.316 0.01 DBMET02948 | ||
| 0.584 | 0.017 | 0.584 | Thioredoxin glutathione reductase inhibitor | |||
| 0.563 | 0.004 | 0.563 | Amyloid beta precursor protein antagonist | 0.35 0.009 DBMET02948 | ||
| 0.541 | 0.005 | 0.599 | Platelet adhesion inhibitor | 0.599 0.004 DBMET02948 | DBMET02948 | |
| 0.514 | 0.019 | 0.634 | Apoptosis antagonist | 0.634 0.006 DBMET02948 | DBMET02948 | |
| 0.48 | 0.022 | 0.775 | Antioxidant | 0.775 0.005 DBMET02948 | DBMET02948 | |
| 0.458 | 0.039 | 0.458 | GABA C receptor rho-3 antagonist | |||
| 0.483 | 0.067 | 0.545 | Caspase 9 stimulant | 0.545 0.046 DBMET02948 | DBMET02948 | |
| 0.434 | 0.042 | 0.434 | Aldehyde oxidase inhibitor | |||
| 0.47 | 0.084 | 0.697 | Apoptosis agonist | 0.697 0.031 DBMET02948 | DBMET02948 | |
| 0.392 | 0.019 | 0.392 | RNA-directed DNA polymerase inhibitor | 0.39 0.019 DBMET02948 | ||
| 0.391 | 0.078 | 0.391 | 15-Lipoxygenase inhibitor | |||
| 0.351 | 0.054 | 0.589 | Vasodilator, coronary | 0.589 0.008 DBMET02948 | DBMET02948 | |
| 0.306 | 0.01 | 0.306 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.396 | 0.104 | 0.396 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.301 | 0.016 | 0.555 | Alpha-N-acetylglucosaminidase inhibitor | 0.555 0.004 DBMET02948 | DBMET02948 | |
| 0.323 | 0.046 | 0.672 | Free radical scavenger | 0.672 0.005 DBMET02948 | DBMET02948 | |
| 0.305 | 0.031 | 0.305 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.271 | 0.004 | 0.271 | Interleukin 5 antagonist | 0.168 0.008 DBMET02948 | ||
| 0.325 | 0.067 | 0.325 | 12-Lipoxygenase inhibitor | |||
| 0.282 | 0.033 | 0.458 | DNA methyltransferase I inhibitor | 0.458 0.005 DBMET02948 | DBMET02948 | |
| 0.293 | 0.045 | 0.293 | Antimitotic | 0.139 0.134 DBMET02948 | ||
| 0.244 | 0.013 | 0.276 | Mannose-6-phosphate isomerase inhibitor | 0.276 0.008 DBMET02948 | DBMET02948 | |
| 0.25 | 0.022 | 0.25 | Succinate dehydrogenase inhibitor | |||
| 0.305 | 0.087 | 0.305 | Calcium channel activator | |||
| 0.219 | 0.005 | 0.219 | CDC25A inhibitor | 0.099 0.028 DBMET02948 | ||
| 0.256 | 0.045 | 0.457 | DNA methylase inhibitor | 0.457 0.008 DBMET02948 | DBMET02948 | |
| 0.23 | 0.027 | 0.663 | Monophenol monooxygenase inhibitor | 0.663 0.004 DBMET02948 | DBMET02948 | |
| 0.282 | 0.08 | 0.282 | Lipoxygenase inhibitor | |||
| 0.332 | 0.132 | 0.44 | 5 Hydroxytryptamine release inhibitor | 0.44 0.056 DBMET02948 | DBMET02948 | |
| 0.228 | 0.029 | 0.228 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.274 | 0.076 | 0.274 | Insulysin inhibitor | |||
| 0.211 | 0.023 | 0.211 | Arachidonic acid antagonist | 0.168 0.068 DBMET02948 | ||
| 0.258 | 0.073 | 0.258 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.199 | 0.018 | 0.432 | UDP-glucose 4-epimerase inhibitor | 0.432 0.004 DBMET02948 | DBMET02948 | |
| 0.229 | 0.048 | 0.229 | Insulin sensitizer | 0.229 0.048 DBMET02948 | ||
| 0.224 | 0.045 | 0.224 | Mcl-1 antagonist | |||
| 0.329 | 0.151 | 0.329 | MAP kinase 1 inhibitor | |||
| 0.183 | 0.017 | 0.286 | Photosensitizer | 0.286 0.004 DBMET02948 | DBMET02948 | |
| 0.271 | 0.11 | 0.72 | Antithrombotic | 0.72 0.007 DBMET02948 | DBMET02948 | |
| 0.274 | 0.115 | 0.274 | Prostaglandin dehydrogenase inhibitor | |||
| 0.24 | 0.083 | 0.24 | Aryl hydrocarbon receptor agonist | |||
| 0.305 | 0.152 | 0.305 | Transcription factor inhibitor | |||
| 0.251 | 0.099 | 0.344 | Hypoxia-inducible factor 1 alpha inhibitor | 0.344 0.047 DBMET02948 | DBMET02948 | |
| 0.211 | 0.064 | 0.211 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.17 0.108 DBMET02948 | ||
| 0.289 | 0.144 | 0.678 | Antibacterial | 0.678 0.01 DBMET02948 | DBMET02948 | |
| 0.151 | 0.006 | 0.151 | CDC25B inhibitor | 0.063 0.046 DBMET02948 | ||
| 0.16 | 0.017 | 0.353 | Triose-phosphate isomerase inhibitor | 0.353 0.004 DBMET02948 | DBMET02948 | |
| 0.228 | 0.086 | 0.228 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.16 | 0.024 | 0.162 | Ca2+-transporting ATPase inhibitor | 0.162 0.021 DBMET02948 | DBMET02948 | |
| 0.256 | 0.12 | 0.256 | Thyroid hormone antagonist | |||
| 0.252 | 0.117 | 0.252 | Thyroid hormone beta antagonist | |||
| 0.183 | 0.049 | 0.437 | Melanin inhibitor | 0.437 0.01 DBMET02948 | DBMET02948 | |
| 0.194 | 0.061 | 0.194 | Peroxidase inhibitor | |||
| 0.149 | 0.016 | 0.149 | CYP2A6 inhibitor | |||
| 0.149 | 0.018 | 0.149 | Anabolic | 0.106 0.054 DBMET02948 | ||
| 0.162 | 0.032 | 0.231 | Microtubule formation inhibitor | 0.231 0.013 DBMET02948 | DBMET02948 | |
| 0.151 | 0.021 | 0.176 | CC chemokine 6 receptor antagonist | 0.176 0.006 DBMET02948 | DBMET02948 | |
| 0.252 | 0.123 | 0.574 | Cholesterol antagonist | 0.574 0.022 DBMET02948 | DBMET02948 | |
| 0.253 | 0.125 | 0.677 | Transcription factor NF kappa B inhibitor | 0.677 0.023 DBMET02948 | DBMET02948 | |
| 0.158 | 0.031 | 0.158 | GABA C receptor agonist | |||
| 0.146 | 0.021 | 0.146 | Porphobilinogen synthase inhibitor | |||
| 0.164 | 0.04 | 0.214 | Aldehyde dehydrogenase inhibitor | 0.214 0.025 DBMET02948 | DBMET02948 | |
| 0.225 | 0.103 | 0.225 | 5 Hydroxytryptamine release stimulant | 0.176 0.145 DBMET02948 | ||
| 0.156 | 0.035 | 0.156 | Ferrochelatase inhibitor | |||
| 0.22 | 0.1 | 0.297 | DNA damaging | 0.297 0.058 DBMET02948 | DBMET02948 | |
| 0.148 | 0.03 | 0.148 | Caspase 3 inhibitor | |||
| 0.201 | 0.087 | 0.226 | Nitric-oxide synthase stimulant | 0.226 0.053 DBMET02948 | DBMET02948 | |
| 0.138 | 0.025 | 0.138 | Electrolyte absorption antagonist | |||
| 0.195 | 0.084 | 0.195 | Pyruvate kinase inhibitor | |||
| 0.141 | 0.03 | 0.141 | Adenylate kinase inhibitor | 0.12 0.043 DBMET02948 | ||
| 0.164 | 0.054 | 0.164 | MAO inhibitor | |||
| 0.169 | 0.059 | 0.349 | Hexokinase inhibitor | 0.349 0.006 DBMET02948 | DBMET02948 | |
| 0.138 | 0.028 | 0.138 | DOPA decarboxylase inhibitor | |||
| 0.116 | 0.006 | 0.116 | Potassium channel Kv1.3 blocker | |||
| 0.127 | 0.019 | 0.127 | Bromodomain-containing protein 2 inhibitor | |||
| 0.164 | 0.057 | 0.164 | GABA C receptor rho-2 antagonist | |||
| 0.144 | 0.039 | 0.144 | MAO B inhibitor | |||
| 0.119 | 0.014 | 0.119 | Alcohol oxidase inhibitor | |||
| 0.278 | 0.174 | 0.278 | DNA directed DNA polymerase inhibitor | |||
| 0.28 | 0.176 | 0.28 | DNA polymerase beta inhibitor | |||
| 0.25 | 0.149 | 0.25 | Calpain 2 inhibitor | |||
| 0.163 | 0.063 | 0.349 | Interferon gamma antagonist | 0.349 0.014 DBMET02948 | DBMET02948 | |
| 0.208 | 0.109 | 0.208 | Superoxide dismutase inhibitor | |||
| 0.208 | 0.111 | 0.405 | DNA synthesis inhibitor | 0.405 0.021 DBMET02948 | DBMET02948 | |
| 0.111 | 0.015 | 0.111 | Elastase 1 inhibitor | |||
| 0.252 | 0.156 | 0.252 | Beta lactamase inhibitor | |||
| 0.118 | 0.029 | 0.265 | NADH dehydrogenase inhibitor | 0.265 0.007 DBMET02948 | DBMET02948 | |
| 0.106 | 0.02 | 0.12 | T cell inhibitor | 0.12 0.014 DBMET02948 | DBMET02948 | |
| 0.154 | 0.068 | 0.154 | CF transmembrane conductance regulator agonist | |||
| 0.182 | 0.096 | 0.182 | Histone acetyltransferase inhibitor | |||
| 0.113 | 0.027 | 0.247 | Phosphofructokinase-1 inhibitor | 0.247 0.008 DBMET02948 | DBMET02948 | |
| 0.149 | 0.065 | 0.149 | Adenylate cyclase stimulant | |||
| 0.148 | 0.065 | 0.508 | Amylase inhibitor | 0.508 0.005 DBMET02948 | DBMET02948 | |
| 0.164 | 0.082 | 0.164 | Phospholipase C inhibitor | 0.16 0.087 DBMET02948 | ||
| 0.141 | 0.059 | 0.141 | Toll-Like receptor 2 antagonist | |||
| 0.081 | 0.002 | 0.081 | Elastase 2B inhibitor | 0.037 0.011 DBMET02948 | ||
| 0.081 | 0.002 | 0.081 | Elastase 3B inhibitor | 0.037 0.011 DBMET02948 | ||
| 0.081 | 0.002 | 0.081 | Elastase 3A inhibitor | 0.037 0.011 DBMET02948 | ||
| 0.105 | 0.027 | 0.135 | Na+ K+ transporting ATPase inhibitor | 0.135 0.01 DBMET02948 | DBMET02948 | |
| 0.119 | 0.041 | 0.119 | Creatine kinase inhibitor | |||
| 0.085 | 0.007 | 0.134 | Glucose-6-phosphate isomerase inhibitor | 0.134 0.003 DBMET02948 | DBMET02948 | |
| 0.109 | 0.033 | 0.109 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.175 | 0.104 | 0.22 | Neurotrophic factor enhancer | 0.22 0.059 DBMET02948 | DBMET02948 | |
| 0.121 | 0.05 | 0.121 | 5-Lipoxygenase inhibitor | |||
| 0.124 | 0.055 | 0.155 | Cystathionine beta-synthase inhibitor | 0.155 0.039 DBMET02948 | DBMET02948 | |
| 0.073 | 0.011 | 0.073 | CXC chemokine 1 receptor antagonist | |||
| 0.085 | 0.024 | 0.085 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.084 | 0.024 | 0.084 | Argininosuccinate synthase inhibitor | 0.061 0.036 DBMET02948 | ||
| 0.067 | 0.01 | 0.067 | Dopamine beta hydroxylase inhibitor | |||
| 0.123 | 0.067 | 0.123 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.14 | 0.083 | 0.14 | Cytidine deaminase inhibitor | |||
| 0.07 | 0.014 | 0.07 | Pregnane X receptor antagonist | |||
| 0.095 | 0.039 | 0.095 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.095 | 0.042 | 0.095 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.112 | 0.06 | 0.112 | Falcipain 3 inhibitor | |||
| 0.137 | 0.086 | 0.155 | Heat shock protein 70 antagonist | 0.155 0.036 DBMET02948 | DBMET02948 | |
| 0.074 | 0.023 | 0.074 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.088 | 0.037 | 0.088 | Glutamate decarboxylase inhibitor | |||
| 0.225 | 0.176 | 0.46 | Histamine release inhibitor | 0.46 0.045 DBMET02948 | DBMET02948 | |
| 0.087 | 0.038 | 0.094 | GABA aminotransferase inhibitor | 0.094 0.032 DBMET02948 | DBMET02948 | |
| 0.098 | 0.05 | 0.148 | Thioredoxin inhibitor | 0.148 0.017 DBMET02948 | DBMET02948 | |
| 0.101 | 0.053 | 0.143 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.143 0.029 DBMET02948 | DBMET02948 | |
| 0.07 | 0.026 | 0.087 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.087 0.018 DBMET02948 | DBMET02948 | |
| 0.073 | 0.03 | 0.073 | Purinergic P2X1 antagonist | |||
| 0.076 | 0.033 | 0.076 | Glutamate (mGluR7) antagonist | |||
| 0.087 | 0.045 | 0.087 | Thioredoxin reductase inhibitor | |||
| 0.05 | 0.009 | 0.05 | Catechol O-methyltransferase inhibitor | |||
| 0.099 | 0.058 | 0.099 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.083 | 0.042 | 0.083 | Glutamate dehydrogenase inhibitor | 0.069 0.058 DBMET02948 | ||
| 0.079 | 0.04 | 0.082 | Glycine receptor agonist | 0.082 0.036 DBMET02948 | DBMET02948 | |
| 0.08 | 0.041 | 0.08 | GABA B receptor agonist | |||
| 0.203 | 0.165 | 0.352 | Caspase 3 stimulant | 0.352 0.058 DBMET02948 | DBMET02948 | |
| 0.08 | 0.042 | 0.08 | Histidine decarboxylase inhibitor | |||
| 0.1 | 0.063 | 0.1 | GABA C receptor rho-1 antagonist | |||
| 0.07 | 0.034 | 0.07 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.062 | 0.027 | 0.062 | Dihydroorotate oxidase inhibitor | |||
| 0.175 | 0.142 | 0.175 | Calpain inhibitor | |||
| 0.104 | 0.072 | 0.104 | GABA C receptor antagonist | |||
| 0.179 | 0.147 | 0.179 | Streptokinase A inhibitor | |||
| 0.066 | 0.035 | 0.066 | Biliverdin reductase inhibitor | |||
| 0.081 | 0.05 | 0.081 | Macrophage migration inhibitory factor inhibitor | |||
| 0.07 | 0.04 | 0.07 | Glutamate (mGluR6) antagonist | |||
| 0.052 | 0.024 | 0.052 | Dopamine D5 antagonist | |||
| 0.051 | 0.024 | 0.051 | Benzodiazepine inverse agonist | |||
| 0.107 | 0.081 | 0.107 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.137 | 0.111 | 0.137 | Dual specificity phosphatase inhibitor | |||
| 0.181 | 0.157 | 0.181 | Neuropeptide Y2 antagonist | |||
| 0.128 | 0.104 | 0.128 | Pregnane X receptor agonist | |||
| 0.043 | 0.018 | 0.043 | Glutamate (mGluR8) agonist | |||
| 0.055 | 0.032 | 0.055 | Aconitate hydratase inhibitor | |||
| 0.031 | 0.008 | 0.031 | Glutamate (mGluR1a) agonist | |||
| 0.034 | 0.012 | 0.034 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.057 | 0.036 | 0.057 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.102 | 0.082 | 0.102 | Acetylcholine release stimulant | |||
| 0.056 | 0.037 | 0.056 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.056 | 0.039 | 0.056 | Ribonucleotide reductase inhibitor | |||
| 0.133 | 0.115 | 0.473 | Nitric oxide antagonist | 0.473 0.018 DBMET02948 | DBMET02948 | |
| 0.049 | 0.032 | 0.049 | Cholesterol esterase inhibitor | |||
| 0.05 | 0.034 | 0.05 | CD45 antagonist | |||
| 0.118 | 0.102 | 0.317 | Cell wall synthesis inhibitor | 0.317 0.009 DBMET02948 | DBMET02948 | |
| 0.067 | 0.051 | 0.067 | Exportin-1 inhibitor | |||
| 0.081 | 0.065 | 0.081 | Estrogen-related receptor beta agonist | |||
| 0.027 | 0.013 | 0.027 | Complement factor 1s inhibitor | |||
| 0.063 | 0.049 | 0.063 | Aryl hydrocarbon receptor antagonist | |||
| 0.08 | 0.067 | 0.08 | Factor XII inhibitor | |||
| 0.067 | 0.055 | 0.067 | Benzodiazepine agonist | |||
| 0.041 | 0.03 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.048 | 0.037 | 0.048 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.028 | 0.016 | 0.028 | Nicotinic acid receptor 2 antagonist | |||
| 0.038 | 0.027 | 0.038 | Potassium channel Kv1.1 blocker | |||
| 0.109 | 0.101 | 0.152 | Alkaline phosphatase inhibitor | 0.152 0.059 DBMET02948 | DBMET02948 | |
| 0.126 | 0.118 | 0.126 | Heat shock protein 90 alpha antagonist | |||
| 0.077 | 0.07 | 0.077 | Caspase 7 inhibitor | |||
| 0.171 | 0.165 | 0.171 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.098 | 0.092 | 0.098 | TRPA1 agonist | |||
| 0.032 | 0.028 | 0.032 | Phosphoglycerate kinase inhibitor | |||
| 0.097 | 0.093 | 0.117 | Beta amyloid protein antagonist | 0.117 0.071 DBMET02948 | DBMET02948 | |
| 0.073 | 0.069 | 0.119 | Glycine receptor antagonist | 0.119 0.018 DBMET02948 | DBMET02948 | |
| 0.024 | 0.02 | 0.043 | Vanilloid 2 agonist | 0.043 0.004 DBMET02948 | DBMET02948 | |
| 0.025 | 0.021 | 0.025 | CXC chemokine 2 receptor antagonist | |||
| 0.031 | 0.028 | 0.031 | Melatonin receptor 1A agonist | |||
| 0.059 | 0.056 | 0.059 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.082 | 0.079 | 0.082 | MAO A inhibitor | |||
| 0.083 | 0.08 | 0.087 | Glutamate release inhibitor | 0.087 0.071 DBMET02948 | DBMET02948 | |
| 0.016 | 0.014 | 0.027 | Telomerase stimulant | 0.027 0.004 DBMET02948 | DBMET02948 | |
| 0.12 | 0.118 | 0.12 | Thiol protease inhibitor | |||
| 0.038 | 0.037 | 0.038 | Kainate receptor agonist | |||
| 0.083 | 0.085 | 0.201 | Xanthine oxidase inhibitor | 0.201 0.019 DBMET02948 | DBMET02948 | |
| 0.022 | 0.029 | 0.108 | Sodium/glucose cotransporter 2 inhibitor | 0.108 0.003 DBMET02948 | DBMET02948 | |
| 0.052 | 0.06 | 0.075 | Lipocortins synthesis agonist | 0.075 0.017 DBMET02948 | DBMET02948 | |
| 0.109 | 0.117 | 0.115 | Vanilloid 1 agonist | 0.115 0.101 DBMET02948 | DBMET02948 | |
| 0.104 | 0.114 | 0.194 | DNA repair enzyme inhibitor | 0.194 0.01 DBMET02948 | DBMET02948 | |
| 0.086 | 0.097 | 0.285 | Beta glucuronidase inhibitor | 0.285 0.007 DBMET02948 | DBMET02948 | |
| 0.015 | 0.028 | 0.031 | Antibiotic Anthracycline-like | 0.031 0.004 DBMET02948 | DBMET02948 | |
| 0.033 | 0.047 | 0.043 | Guanylate cyclase inhibitor | 0.043 0.029 DBMET02948 | DBMET02948 | |
| 0.02 | 0.04 | 0.09 | Sodium/glucose cotransporter inhibitor | 0.09 0.003 DBMET02948 | DBMET02948 | |
| 0.006 | 0.027 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.007 DBMET02948 | DBMET02948 | |
| 0.083 | 0.112 | 0.211 | Alkylator | 0.211 0.023 DBMET02948 | DBMET02948 | |
| 0.04 | 0.071 | 0.097 | Alpha-mannosidase inhibitor | 0.097 0.007 DBMET02948 | DBMET02948 | |
| 0.119 | 0.151 | 0.145 | Anesthetic general | 0.145 0.119 DBMET02948 | DBMET02948 | |
| 0.079 | 0.115 | 0.11 | Mucolytic | 0.11 0.064 DBMET02948 | DBMET02948 | |
| 0.048 | 0.089 | 0.089 | Carbonic anhydrase XIII inhibitor | 0.089 0.044 DBMET02948 | DBMET02948 | |
| 0.101 | 0.142 | 0.164 | Protein-tyrosine phosphatase inhibitor | 0.164 0.067 DBMET02948 | DBMET02948 | |
| 0.011 | 0.057 | 0.021 | Corticosteroid-like | 0.021 0.014 DBMET02948 | DBMET02948 | |
| 0.026 | 0.079 | 0.091 | Mannosidase inhibitor | 0.091 0.007 DBMET02948 | DBMET02948 | |
| 0.048 | 0.103 | 0.222 | Topoisomerase II alpha inhibitor | 0.222 0.012 DBMET02948 | DBMET02948 | |
| 0.115 | 0.181 | 0.278 | Non-steroidal antiinflammatory agent | 0.278 0.033 DBMET02948 | DBMET02948 | |
| 0.078 | 0.149 | 0.229 | Cyclooxygenase 3 inhibitor | 0.229 0.011 DBMET02948 | DBMET02948 | |
| 0.127 | 0.201 | 0.274 | Cyclic AMP phosphodiesterase inhibitor | 0.274 0.053 DBMET02948 | DBMET02948 | |
| 0.085 | 0.161 | 0.206 | Protein kinase stimulant | 0.206 0.039 DBMET02948 | DBMET02948 | |
| 0.059 | 0.138 | 0.268 | Expectorant | 0.268 0.011 DBMET02948 | DBMET02948 | |
| 0.115 | 0.195 | 0.394 | Platelet antagonist | 0.394 0.028 DBMET02948 | DBMET02948 | |
| 0.007 | 0.103 | 0.041 | Arginase inhibitor | 0.041 0.021 DBMET02948 | DBMET02948 | |
| 0.061 | 0.16 | 0.17 | DNA polymerase I inhibitor | 0.17 0.039 DBMET02948 | DBMET02948 | |
| 0.106 | 0.206 | 0.237 | Antiamyloidogenic | 0.237 0.077 DBMET02948 | DBMET02948 | |
| 0.028 | 0.134 | 0.247 | Antineoplastic antibiotic | 0.247 0.014 DBMET02948 | DBMET02948 | |
| 0.023 | 0.141 | 0.053 | Microtubule stabilization | 0.053 0.023 DBMET02948 | DBMET02948 | |
| 0.1 | 0.22 | 0.445 | Immunostimulant | 0.445 0.038 DBMET02948 | DBMET02948 | |
| 0.002 | 0.125 | 0.015 | Antibiotic Macrolide-like | 0.015 0.009 DBMET02948 | DBMET02948 | |
| 0.028 | 0.152 | 0.091 | Heparanase inhibitor | 0.091 0.005 DBMET02948 | DBMET02948 | |
| 0.041 | 0.176 | 0.135 | Protein-tyrosine phosphatase 1B inhibitor | 0.135 0.052 DBMET02948 | DBMET02948 | |
| 0.137 | 0.274 | 0.529 | Immunosuppressant | 0.529 0.025 DBMET02948 | DBMET02948 | |
| 0.091 | 0.228 | 0.265 | Interleukin agonist | 0.265 0.068 DBMET02948 | DBMET02948 | |
| 0.046 | 0.187 | 0.299 | Topoisomerase II inhibitor | 0.299 0.018 DBMET02948 | DBMET02948 | |
| 0.1 | 0.243 | 0.231 | ATPase inhibitor | 0.231 0.019 DBMET02948 | DBMET02948 | |
| 0.025 | 0.196 | 0.102 | Glucose-6-phosphate translocase inhibitor | 0.102 0.006 DBMET02948 | DBMET02948 | |
| 0.078 | 0.275 | 0.186 | Spasmolytic | 0.186 0.132 DBMET02948 | DBMET02948 | |
| 0.053 | 0.256 | 0.087 | Phosphodiesterase 6D inhibitor | 0.087 0.084 DBMET02948 | DBMET02948 | |
| 0.017 | 0.221 | 0.123 | Protein 50S ribosomal subunit inhibitor | 0.123 0.009 DBMET02948 | DBMET02948 | |
| 0.006 | 0.217 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.014 DBMET02948 | DBMET02948 | |
| 0.044 | 0.258 | 0.114 | Multidrug resistance-associated protein 1 inhibitor | 0.114 0.056 DBMET02948 | DBMET02948 | |
| 0.027 | 0.244 | 0.056 | Factor III inhibitor | 0.056 0.022 DBMET02948 | DBMET02948 | |
| 0.006 | 0.226 | 0.021 | Dopamine D1 agonist | 0.021 0.018 DBMET02948 | DBMET02948 | |
| 0.032 | 0.266 | 0.105 | Mediator release inhibitor | 0.105 0.065 DBMET02948 | DBMET02948 | |
| 0.054 | 0.299 | 0.141 | Diuretic | 0.141 0.084 DBMET02948 | DBMET02948 | |
| 0.004 | 0.255 | 0.077 | Estrogen receptor beta agonist | 0.077 0.015 DBMET02948 | DBMET02948 | |
| 0.006 | 0.275 | 0.079 | Estrogen agonist | 0.079 0.023 DBMET02948 | DBMET02948 | |
| 0.102 | 0.413 | 0.416 | Peptidyltransferase inhibitor | 0.416 0.006 DBMET02948 | DBMET02948 | |
| 0.029 | 0.354 | 0.136 | AMP-activated protein kinase stimulant | 0.136 0.037 DBMET02948 | DBMET02948 | |
| 0.056 | 0.383 | 0.475 | Hepatoprotectant | 0.475 0.008 DBMET02948 | DBMET02948 | |
| 0.019 | 0.368 | 0.244 | Topoisomerase I inhibitor | 0.244 0.018 DBMET02948 | DBMET02948 | |
| 0.006 | 0.396 | 0.064 | Protein 30S ribosomal subunit inhibitor | 0.064 0.005 DBMET02948 | DBMET02948 | |
| 0.032 | 0.423 | 0.763 | Angiogenesis stimulant | 0.763 0.004 DBMET02948 | DBMET02948 | |
| 0.041 | 0.451 | 0.193 | Hemostatic | 0.193 0.035 DBMET02948 | DBMET02948 | |
| 0.024 | 0.444 | 0.298 | Lipid peroxidase inhibitor | 0.298 0.019 DBMET02948 | DBMET02948 | |
| 0.009 | 0.478 | 0.09 | Neuraminidase (influenza) inhibitor | 0.09 0.02 DBMET02948 | DBMET02948 | |
| 0.009 | 0.488 | 0.054 | Neuraminidase (Influenza A) inhibitor | 0.054 0.019 DBMET02948 | DBMET02948 | |
| 0.005 | 0.549 | 0.078 | Neuraminidase inhibitor | 0.078 0.027 DBMET02948 | DBMET02948 | |
| 0.015 | 0.569 | 0.116 | Uric acid excretion stimulant | 0.116 0.04 DBMET02948 | DBMET02948 | |
| 0.036 | 0.64 | 0.297 | NOS3 expression enhancer | 0.297 0.018 DBMET02948 | DBMET02948 | |
| 0.01 | 0.618 | 0.082 | Antibiotic Aminoglycoside-like | 0.082 0.004 DBMET02948 | DBMET02948 | |
| 0.019 | 0.63 | 0.065 | Adenine nucleotide translocase inhibitor | 0.065 0.02 DBMET02948 | DBMET02948 | |
| 0.004 | 0.649 | 0.05 | Aldose reductase inhibitor | 0.05 0.039 DBMET02948 | DBMET02948 | |
| 0.005 | 0.655 | 0.37 | Selectin antagonist | 0.37 0.004 DBMET02948 | DBMET02948 | |
| 0.025 | 0.701 | 0.113 | Interleukin 4 antagonist | 0.113 0.097 DBMET02948 | DBMET02948 | |
| 0.011 | 0.693 | 0.12 | ATPase (Vacuolar H+) inhibitor | 0.12 0.019 DBMET02948 | DBMET02948 | |
| 0.025 | 0.729 | 0.133 | Transcription factor NF kappa B stimulant | 0.133 0.02 DBMET02948 | DBMET02948 | |
| 0.018 | 0.734 | 0.16 | Toll-Like receptor 4 antagonist | 0.16 0.016 DBMET02948 | DBMET02948 | |
| 0.01 | 0.73 | 0.071 | Histone deacetylase stimulant | 0.071 0.054 DBMET02948 | DBMET02948 | |
| 0.01 | 0.73 | 0.071 | Histone deacetylase SIRT1 stimulant | 0.071 0.054 DBMET02948 | DBMET02948 | |
| 0.054 | 0.793 | 0.421 | Interleukin 2 agonist | 0.421 0.022 DBMET02948 | DBMET02948 | |
| 0.007 | 0.798 | 0.089 | DNA intercalator | 0.089 0.087 DBMET02948 | DBMET02948 | |
| 0.008 | 0.834 | 0.262 | Vasodilator | 0.262 0.063 DBMET02948 | DBMET02948 | |
| 0.007 | 0.847 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 DBMET02948 | DBMET02948 | |
| 0.01 | 0.878 | 0.075 | Factor IXa inhibitor | 0.075 0.018 DBMET02948 | DBMET02948 | |
| 0.002 | 0.879 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 DBMET02948 | DBMET02948 | |
| 0.005 | 0.95 | 0.272 | Thrombolytic | 0.272 0.029 DBMET02948 | DBMET02948 | |
| 0.006 | 0.958 | 0.139 | Interleukin 6 antagonist | 0.139 0.107 DBMET02948 | DBMET02948 | |
| 0.004 | 0.97 | 0.18 | Cell adhesion inhibitor | 0.18 0.031 DBMET02948 | DBMET02948 | |
| 0.005 | 0.973 | 0.649 | Antiinflammatory | 0.649 0.041 DBMET02948 | DBMET02948 | |
| 0.005 | 0.975 | 0.188 | Insulin secretagoues | 0.188 0.043 DBMET02948 | DBMET02948 | |
| 0.005 | 0.977 | 0.275 | Immunomodulator | 0.275 0.097 DBMET02948 | DBMET02948 | |
| 0.004 | 0.977 | 0.256 | Tumour necrosis factor alpha release inhibitor | 0.256 0.072 DBMET02948 | DBMET02948 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |